Shares Of Vical Tumbled 43% After Reporting Failed Results In Herpes Vaccine
June 23, 2015 at 18:55 PM EDT
Shares of Vical (VICL) closed down 43% today after the company reported negative results in its Phase 1/2 trial in patients with Herpes.
